Filing Details
- Accession Number:
- 0001787306-24-000108
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-07-02 19:13:16
- Reporting Period:
- 2024-07-01
- Accepted Time:
- 2024-07-02 19:13:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1787306 | Arcutis Biotherapeutics Inc. | ARQT | Pharmaceutical Preparations (2834) | 812974255 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1801050 | G. Howard Welgus | C/O Arcutis Biotherapeutics, Inc. 3027 Townsgate Road, Suite 300 Westlake Village CA 91361 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-07-01 | 5,681 | $1.68 | 186,020 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2024-07-01 | 4,319 | $1.68 | 190,339 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-07-01 | 10,000 | $9.31 | 180,339 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2024-07-01 | 5,681 | $0.00 | 5,681 | $1.68 |
| Common Stock | Stock Option (right to buy) | Disposition | 2024-07-01 | 4,319 | $0.00 | 4,319 | $1.68 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2029-03-13 | No | 4 | M | Direct | |
| 6,614 | 2029-03-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 24,991 | Indirect | By Trust |
Footnotes
- The transaction reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
- The securities are held of record by The Welgus Living Trust, of which the Reporting Person is trustee. The Reporting Person disclaims beneficial ownership of such securities except to the extent of his pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of such securities for purposes of Section 16 or for any other purposes.
- This option is fully vested.
Billionaire Hedge Funds
